|Articles|June 1, 2022
SEC-MALS Method for Characterizing mRNA v3
Author(s)Wyatt
SEC-MALS quantifies biophysical attributes of mRNA, including molar mass, percent aggregates, Rg and Rh, and how they are affected by formulation and storage conditions.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Formulation Strategies, Tech Advances, Challenges, and Considerations in Novel Drug Delivery
2
Regulatory Uncertainty Surfaces as FDA Blames COVID Vaccines for 10 Child Deaths
3
Drug Digest: Biopharma Landscape Evolves Through Strategic Alliances and Technology Integration
4
FAQ: What You Need to Know About How Industry is Tackling CGT Bottlenecks
5
